Want to buy a stock? Check the related industry trend and it's relative strength. Enter a stock ticker here:

Don’t fight the industry trends – ride them!

Register for free alerts

 


Sector Trends Service: which vehicle to choose?


Useful links

Narrow your search and focus on stocks with strongest bullish (or bearish) signals.
In the first two tables tickers are sorted according to their rating.

Pharmaceuticals: best performers


For bullish play focus on tickers with maximum number of green stars. Buy full access to our PDF reports with in-depth analysis.

Our Rating

Capitalization

Closing price

LONG-TERM

SHORT-TERM

Outlook

Relative Strength

Outlook

Relative Strength

CHTT

Buy

376.89M

72 (0.8)

CHTT long-term outlook: bullish

CHTT long-term strength in the Pharmaceuticals industry: underperform

CHTT short-term outlook: bullish

CHTT short-term strength in the Pharmaceuticals industry: outperform

JNJ

Buy

161.69B

67.94 (0.24)

JNJ long-term outlook: bullish

JNJ long-term strength in the Pharmaceuticals industry: underperform

JNJ short-term outlook: bullish

JNJ short-term strength in the Pharmaceuticals industry: outperform

PRGO

Buy

1.08B

32.64 (0.9)

PRGO long-term outlook: bullish

PRGO long-term strength in the Pharmaceuticals industry: underperform

PRGO short-term outlook: bullish

PRGO short-term strength in the Pharmaceuticals industry: outperform

SGP

Buy

29.39B

28.68 (0.74)

SGP long-term outlook: bullish

SGP long-term strength in the Pharmaceuticals industry: underperform

SGP short-term outlook: bullish

SGP short-term strength in the Pharmaceuticals industry: outperform

AGN

Neutral

10.33B

65.33 (0.2)

AGN long-term outlook: very bullish

AGN long-term strength in the Pharmaceuticals industry: underperform

AGN short-term outlook: very bullish

AGN short-term strength in the Pharmaceuticals industry: underperform


Pharmaceuticals: worst performers


For bearish play focus on tickers with maximum number of red stars. Buy full access to our PDF reports with in-depth analysis.

Our Rating

Capitalization

Closing price

LONG-TERM

SHORT-TERM

Outlook

Relative Strength

Outlook

Relative Strength

BIO

Sell

1.43B

102.08 (0.58)

BIO long-term outlook: bullish

BIO long-term strength in the Pharmaceuticals industry: underperform

BIO short-term outlook: bearish

BIO short-term strength in the Pharmaceuticals industry: underperform

AGN

Neutral

10.33B

65.33 (0.2)

AGN long-term outlook: very bullish

AGN long-term strength in the Pharmaceuticals industry: underperform

AGN short-term outlook: very bullish

AGN short-term strength in the Pharmaceuticals industry: underperform

ALO

Neutral

1.17B

20.11 (-0.01)

ALO long-term outlook: bearish

ALO long-term strength in the Pharmaceuticals industry: underperform

ALO short-term outlook: bullish

ALO short-term strength in the Pharmaceuticals industry: underperform

AZN

Neutral

74.08B

46.44 (-0.23)

AZN long-term outlook: bearish

AZN long-term strength in the Pharmaceuticals industry: underperform

AZN short-term outlook: bullish

AZN short-term strength in the Pharmaceuticals industry: underperform

AXCA

Neutral

553.39M

22.6 (0.25)

AXCA long-term outlook: bullish

AXCA long-term strength in the Pharmaceuticals industry: underperform

AXCA short-term outlook: bullish

AXCA short-term strength in the Pharmaceuticals industry: underperform


Pharmaceuticals: maximum capitalization


Looking for robust companies? Here they are sorted according to their capitalization. Buy full access to our PDF reports with in-depth analysis.

Our Rating

Capitalization

closing price

LONG-TERM

SHORT-TERM

Outlook

Relative Strength

Outlook

Relative Strength

PFE

Neutral

280.80B

23.67 (-0.14)

PFE long-term outlook: bearish

PFE long-term strength in the Pharmaceuticals industry: underperform

PFE short-term outlook: very bullish

PFE short-term strength in the Pharmaceuticals industry: underperform

JNJ

Buy

161.69B

67.94 (0.24)

JNJ long-term outlook: bullish

JNJ long-term strength in the Pharmaceuticals industry: underperform

JNJ short-term outlook: bullish

JNJ short-term strength in the Pharmaceuticals industry: outperform

MRK

Neutral

141.00B

59.82 (0.1)

MRK long-term outlook: bullish

MRK long-term strength in the Pharmaceuticals industry: underperform

MRK short-term outlook: bullish

MRK short-term strength in the Pharmaceuticals industry: underperform

GSK

Neutral

130.30B

53.92 (0.4423)

GSK long-term outlook: very bearish

GSK long-term strength in the Pharmaceuticals industry: outperform

GSK short-term outlook: bullish

GSK short-term strength in the Pharmaceuticals industry: underperform

NVS

Neutral

102.20B

56.29 (0.06)

NVS long-term outlook: very bearish

NVS long-term strength in the Pharmaceuticals industry: underperform

NVS short-term outlook: bullish

NVS short-term strength in the Pharmaceuticals industry: underperform

Click here to get performance analysis for this industry. It helps to identify best stocks to trade.

Buy unlimited one-week access to our comprehensive reports in PDF format for more details (sample).
Outlook estimates are based on MACD indicators.
Relative strength is calculated in the broader industry (or sector).


Our reports use comprehensive multi-level analysis with a sub-industry/industry/sector bottom-up approach. The Reports differ from traditional across-industries comparison reports that show the past performance only. We include the future trends based on a wide range of technical signals that were computed for related industries and sectors. By aggregating industries and computing all technicals we implicitly take into account and reveal the action of the big market players that have an influence on the market.

Technical and Industry Analysis Reports will help you avoid the 5 common mistakes made by traders:

* Betting on a weakening stock in the industry. You will see the relative strength of your stock and find out how it changes over time.

Open pages 3 - 4 and learn how your stock is strengthening (or weakening) against the related industry. Even more, find out how strong the industry is in its sector. Remember that the strength usually fluctuates. Do not ignore the strength changes.


* Ignoring the evidence that the market is showing you. The reports include an extensive set of technical indicators for daily and weekly charts. You won't miss anything.

Open page 5 and find at-a-glance all the most widely used technical indicators with the signals they generate. There is no need to analyze charts. It is already done.


* Fighting an industry trend. We will show you how the strength/weakness of the trend in a stock's related industry/sector.

Open pages 7-18 and look through all technicals for the related sub-industry, industry and sector. This "bottom-up" approach will help you to avoid very risky situations when you go against the industry trend. The "Big Boys" play the "industry rotation game", and you should be aware of it.


* Ignoring all other potential picks in the industry. You will see all technicals for other companies in the same industry and sub-industry. It will help you to double-check your choice and select another, more attractive pick if necessary.

Open pages 6 and 12 and find our Check Lists with the key technical for other stocks (trend setters, best and worst performers) in the related industry and sector.


* Incorrect chart interpretation. You don't need to waste you time to analyze the charts and yet get it wrong. OptionSmart gives you the true picture at-a-glance for you to make the right decision.

Useful links

 

   © www.stocksight.com | contact us. Updated: 12/13/07, 10:12 PM EST